We provide you with 20 years of free, institutional-grade data for RVMD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RVMD. Explore the full financial landscape of RVMD stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$7,297,185
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Cislini Jeff | Sale | -1,799 | $44.26 | $79,624 | 2025-09-26 |
Cislini Jeff | Sale | -1,869 | $45.82 | $85,647 | 2025-09-18 |
Anders Jack | Sale | -2,320 | $45.82 | $106,314 | 2025-09-18 |
Wei Lin | Sale | -2,160 | $45.82 | $98,982 | 2025-09-18 |
Horn Margaret A | Sale | -4,775 | $45.82 | $218,814 | 2025-09-18 |
Kelsey Stephen Michael | Sale | -5,367 | $45.82 | $245,942 | 2025-09-18 |
GOLDSMITH MARK A | Sale | -13,411 | $45.82 | $614,558 | 2025-09-18 |
Kelsey Stephen Michael | Sale | -125,000 | $43.58 | $5,447,138 | 2025-09-15 |
Kelsey Stephen Michael | Derivatives Exercise | 125,000 | 2025-09-15 | ||
Anders Jack | Sale | -10,000 | $40.02 | $400,168 | 2025-09-04 |
Anders Jack | Derivatives Exercise | 10,000 | 2025-09-04 | ||
GOLDSMITH MARK A | Derivatives Exercise | 37,000 | 2025-07-02 | ||
Borellini Flavia | Grant, award...etc | 3,142 | 2025-06-30 | ||
ANDERSON ELIZABETH M | Grant, award...etc | 3,142 | 2025-06-30 | ||
Clyburn Frank | Grant, award...etc | 2,806 | 2025-06-30 | ||
Horning Sandra | Grant, award...etc | 3,142 | 2025-06-30 | ||
Patel Sushil | Grant, award...etc | 3,142 | 2025-06-30 | ||
Kim Lorence H. | Grant, award...etc | 3,142 | 2025-06-30 | ||
Borisy Alexis | Grant, award...etc | 3,142 | 2025-06-30 | ||
Cislini Jeff | Sale | -1,912 | $39.61 | $75,736 | 2025-06-23 |
Wei Lin | Sale | -2,173 | $39.83 | $86,551 | 2025-06-18 |
Kelsey Stephen Michael | Sale | -4,289 | $39.83 | $170,831 | 2025-06-18 |
Anders Jack | Sale | -2,170 | $39.83 | $86,431 | 2025-06-18 |
Cislini Jeff | Sale | -1,878 | $39.83 | $74,801 | 2025-06-18 |
GOLDSMITH MARK A | Sale | -13,496 | $39.83 | $537,546 | 2025-06-18 |
Horn Margaret A | Sale | -3,510 | $39.83 | $139,803 | 2025-06-18 |
Cislini Jeff | Sale | -2,041 | $38.71 | $79,008 | 2025-03-24 |
Horn Margaret A | Sale | -3,058 | $39.04 | $119,385 | 2025-03-19 |
Kelsey Stephen Michael | Sale | -3,294 | $39.04 | $128,599 | 2025-03-19 |
Anders Jack | Sale | -1,864 | $39.04 | $72,771 | 2025-03-19 |
Cislini Jeff | Sale | -1,458 | $39.04 | $56,921 | 2025-03-19 |
GOLDSMITH MARK A | Sale | -11,738 | $39.04 | $458,255 | 2025-03-19 |
Wei Lin | Grant, award...etc | -20,800 | 2025-03-04 | ||
GOLDSMITH MARK A | Grant, award...etc | 97,400 | 2025-03-04 | ||
Wang Xiaolin | Grant, award...etc | 19,000 | 2025-03-04 | ||
Anders Jack | Grant, award...etc | 20,400 | 2025-03-04 | ||
Cislini Jeff | Grant, award...etc | 22,000 | 2025-03-04 | ||
Horn Margaret A | Grant, award...etc | 28,600 | 2025-03-04 | ||
Kelsey Stephen Michael | Grant, award...etc | 36,600 | 2025-03-04 | ||
Cislini Jeff | Sale | -2,406 | $40.5 | $97,443 | 2025-01-22 |
GOLDSMITH MARK A | Derivatives Exercise | 30,846 | 2024-12-20 | ||
Anders Jack | Sale | -2,635 | $45.4 | $119,639 | 2024-12-18 |
Horn Margaret A | Sale | -4,329 | $45.4 | $196,553 | 2024-12-18 |
GOLDSMITH MARK A | Sale | -11,714 | $45.4 | $531,860 | 2024-12-18 |
Cislini Jeff | Sale | -1,599 | $45.4 | $72,601 | 2024-12-18 |
Kelsey Stephen Michael | Sale | -4,663 | $45.4 | $211,718 | 2024-12-18 |
Schroeder Thilo | Open Market Purchase | 760,869 | $46 | 2024-12-09 | |
Schroeder Thilo | Open Market Purchase | 543,478 | $46 | 2024-12-09 | |
Cislini Jeff | Sale | -2,554 | $55.13 | $140,811 | 2024-11-19 |
Kelsey Stephen Michael | Sale | -16,666 | $58.49 | $974,721 | 2024-11-15 |
Kelsey Stephen Michael | Derivatives Exercise | 16,666 | 2024-11-15 | ||
Cislini Jeff | Sale | -6,000 | $60 | $360,000 | 2024-11-08 |
Cislini Jeff | Derivatives Exercise | 6,000 | 2024-11-08 | ||
GOLDSMITH MARK A | Sale | -5,000 | $55.02 | $275,105 | 2024-11-05 |
GOLDSMITH MARK A | Sale | -5,000 | $55.03 | $275,134 | 2024-11-05 |
GOLDSMITH MARK A | Sale | -60,000 | $55.02 | $3,301,410 | 2024-11-05 |
GOLDSMITH MARK A | Derivatives Exercise | 96,600 | 2024-11-05 | ||
Patel Sushil | Sale | -5,000 | $54.14 | $270,715 | 2024-11-04 |
Patel Sushil | Derivatives Exercise | 5,000 | 2024-11-04 | ||
Kelsey Stephen Michael | Sale | -16,666 | $49.38 | $822,987 | 2024-10-16 |
Kelsey Stephen Michael | Derivatives Exercise | 16,666 | 2024-10-16 | ||
Cislini Jeff | Sale | -6,000 | $50.17 | $301,027 | 2024-10-15 |
Cislini Jeff | Derivatives Exercise | 6,000 | 2024-10-15 | ||
GOLDSMITH MARK A | Sale | -30,000 | $50.36 | $1,510,773 | 2024-10-15 |
GOLDSMITH MARK A | Derivatives Exercise | 30,000 | 2024-10-15 | ||
Anders Jack | Sale | -10,000 | $50.3 | $502,979 | 2024-10-15 |
Anders Jack | Derivatives Exercise | 10,000 | 2024-10-15 | ||
Horn Margaret A | Sale | -50,000 | $50.34 | $2,517,055 | 2024-10-15 |
Horn Margaret A | Derivatives Exercise | 50,000 | 2024-10-15 | ||
Weber Barbara | Sale | -5,200 | $48.02 | $249,716 | 2024-10-10 |
GOLDSMITH MARK A | Sale | -10,000 | $44.8 | $447,993 | 2024-10-03 |
GOLDSMITH MARK A | Derivatives Exercise | 10,000 | 2024-10-03 | ||
Cislini Jeff | Sale | -1,454 | $44.19 | $64,245 | 2024-09-18 |
Horn Margaret A | Sale | -4,331 | $44.19 | $191,367 | 2024-09-18 |
Anders Jack | Sale | -2,244 | $44.19 | $99,152 | 2024-09-18 |
GOLDSMITH MARK A | Sale | -11,715 | $44.19 | $517,631 | 2024-09-18 |
Kelsey Stephen Michael | Sale | -4,665 | $44.19 | $206,124 | 2024-09-18 |
Kelsey Stephen Michael | Sale | -16,667 | $42.75 | $712,503 | 2024-09-16 |
Kelsey Stephen Michael | Derivatives Exercise | 16,667 | 2024-09-16 | ||
Kelsey Stephen Michael | Sale | -16,667 | $42.98 | $716,389 | 2024-08-15 |
Kelsey Stephen Michael | Derivatives Exercise | 16,667 | 2024-08-15 | ||
Clyburn Frank | Grant, award...etc | 6,932 | 2024-08-07 | ||
GOLDSMITH MARK A | Sale | -10,000 | $45.6 | $456,004 | 2024-08-02 |
GOLDSMITH MARK A | Derivatives Exercise | 10,000 | 2024-08-02 | ||
Kelsey Stephen Michael | Sale | -16,667 | $43.99 | $733,106 | 2024-07-17 |
Kelsey Stephen Michael | Derivatives Exercise | 16,667 | 2024-07-17 | ||
GOLDSMITH MARK A | Sale | -5,000 | $45.01 | $225,059 | 2024-07-16 |
GOLDSMITH MARK A | Sale | -5,000 | $45.01 | $225,058 | 2024-07-16 |
GOLDSMITH MARK A | Sale | -25,000 | $45.05 | $1,126,205 | 2024-07-16 |
GOLDSMITH MARK A | Derivatives Exercise | 25,000 | 2024-07-16 | ||
Patel Sushil | Sale | -2,155 | $44 | $94,820 | 2024-07-10 |
Patel Sushil | Derivatives Exercise | 2,155 | 2024-07-10 | ||
Cislini Jeff | Sale | -2,399 | $40.83 | $97,951 | 2024-07-10 |
Kim Lorence H. | Grant, award...etc | 4,248 | 2024-06-28 | ||
Borisy Alexis | Grant, award...etc | 4,248 | 2024-06-28 | ||
Patel Sushil | Grant, award...etc | 4,248 | 2024-06-28 | ||
Horning Sandra | Grant, award...etc | 2,945 | 2024-06-28 | ||
Borellini Flavia | Grant, award...etc | 4,248 | 2024-06-28 | ||
ANDERSON ELIZABETH M | Grant, award...etc | 4,248 | 2024-06-28 | ||
Weber Barbara | Grant, award...etc | 4,248 | 2024-06-28 | ||
Cislini Jeff | Sale | -2,000 | $38.47 | $76,940 | 2024-06-27 |
Kelsey Stephen Michael | Sale | -16,667 | $39 | $650,013 | 2024-06-26 |
Kelsey Stephen Michael | Derivatives Exercise | 16,667 | 2024-06-26 | ||
Borisy Alexis | Grant, award...etc | 4,800 | 2024-06-24 | ||
Kim Lorence H. | Grant, award...etc | 4,800 | 2024-06-24 | ||
Weber Barbara | Grant, award...etc | 4,800 | 2024-06-24 | ||
Borellini Flavia | Grant, award...etc | 4,800 | 2024-06-24 | ||
ANDERSON ELIZABETH M | Grant, award...etc | 4,800 | 2024-06-24 | ||
Horning Sandra | Grant, award...etc | 4,800 | 2024-06-24 | ||
Patel Sushil | Grant, award...etc | 4,800 | 2024-06-24 | ||
Cislini Jeff | Sale | -1,757 | $37.39 | $65,690 | 2024-06-20 |
Wei Lin | Sale | -5,589 | $37.39 | $208,954 | 2024-06-20 |
Kelsey Stephen Michael | Sale | -3,349 | $37.39 | $125,209 | 2024-06-20 |
Horn Margaret A | Sale | -4,415 | $37.39 | $165,064 | 2024-06-20 |
GOLDSMITH MARK A | Sale | -11,950 | $37.39 | $446,770 | 2024-06-20 |
Anders Jack | Sale | -1,893 | $37.39 | $70,775 | 2024-06-20 |
The information provided in this report about RVMD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Revolution Medicines, Inc(NASDAQ:RVMD)


Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gyne...
Website: http://www.revmed.com
Founded: 2014
Full Time Employees: 117
CEO: Mark A. Goldsmith
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends